Paul A. Ragusa
Directeur Financier/CFO chez Verax Biomedical, Inc.
Profil
Paul A.
Ragusa is currently the Vice President-Finance & Administration at Verax Biomedical, Inc. He previously worked as a Consultant at Boston Equity Advisors LLC.
He obtained an undergraduate degree from Northeastern University.
Postes actifs de Paul A. Ragusa
| Sociétés | Poste | Début |
|---|---|---|
Verax Biomedical, Inc.
 Verax Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Verax Biomedical, Inc. develops rapid tests for detecting bacterial contaminants in blood cells and tissues. The firm's first target application for its technology is to test for the presence of bacterial contaminants in platelets and bacterial contaminants in platelets and red blood cells represent the greatest lethal infectious risks in transfusion medicine today and no rapid, simple methods are presently available to effectively address this threat. Verax Biomedical was founded by Joe R. Sanders and Joe L. Straight in 1999 and is headquartered in Marlborough, MA. | Directeur Financier/CFO | 05/03/2010 |
Anciens postes connus de Paul A. Ragusa
| Sociétés | Poste | Fin |
|---|---|---|
Boston Equity Advisors LLC
 Boston Equity Advisors LLC Investment Banks/BrokersFinance Boston Equity Advisors LLC is focuses on security brokers, dealers, and flotation companies. The company was founded by Arnold Freedman is headquartered in Canton, MA. | Corporate Officer/Principal | - |
Formation de Paul A. Ragusa
| Northeastern University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Verax Biomedical, Inc.
Verax Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Verax Biomedical, Inc. develops rapid tests for detecting bacterial contaminants in blood cells and tissues. The firm's first target application for its technology is to test for the presence of bacterial contaminants in platelets and bacterial contaminants in platelets and red blood cells represent the greatest lethal infectious risks in transfusion medicine today and no rapid, simple methods are presently available to effectively address this threat. Verax Biomedical was founded by Joe R. Sanders and Joe L. Straight in 1999 and is headquartered in Marlborough, MA. | Commercial Services |
Boston Equity Advisors LLC
Boston Equity Advisors LLC Investment Banks/BrokersFinance Boston Equity Advisors LLC is focuses on security brokers, dealers, and flotation companies. The company was founded by Arnold Freedman is headquartered in Canton, MA. | Finance |
